FIDAS-3
CAS: 1266684-01-8
Ref. 3D-RAC68401
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
FIDAS-3 is an anticancer drug that has been developed as a kinase inhibitor analog of artesunate. It has been shown to be effective in inducing apoptosis in human cancer cells. FIDAS-3 targets kinases that are involved in cell proliferation and survival, leading to the inhibition of tumor growth. This drug has been tested on Chinese hamster ovary cells and human lung cancer cells, showing potent antitumor activity. FIDAS-3 can be detected in urine after administration, making it a promising candidate for clinical trials. The combination of FIDAS-3 with chloroquine has also been shown to increase its anticancer effects by inhibiting autophagy. Overall, FIDAS-3 is a promising new drug for the treatment of cancer that shows great potential for further development.
Chemical properties
Technical inquiry about: 3D-RAC68401 FIDAS-3
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
